Additional value of PCA3 density to predict initial prostate biopsy outcome

被引：0
|
作者：
A. Ruffion
P. Perrin
M. Devonec
D. Champetier
M. Decaussin
P. Paparel
V. Vlaeminck-Guillem
机构：
[1] Hospices Civils de Lyon,Service d’Urologie, Centre Hospitalier Lyon Sud
[2] Université de Lyon,Faculté de Médecine
[3] Université Claude Bernard Lyon 1,Institut de Génomique Fonctionnelle de Lyon, CNRS UMR5242
[4] Université de Lyon,Service d’Anatomie et de Cytologie Pathologiques, Centre Hospitalier Lyon Sud
[5] Université Lyon 1,Unité Médicale d’Oncologie Moléculaire et Transfert, Service de Biochimie biologie moléculaire sud, Centre Hospitalier Lyon Sud
[6] Hospices Civils de Lyon,Centre de Recherche en Cancérologie de Lyon
[7] Hospices Civils de Lyon, INSERM 1052 CNRS 5286
[8] Centre Léon Bérard,undefined
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate cancer; Tumor markers; Urine; PSA; PSA density; Prostate cancer gene 3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 923
页数：6
相关论文
共 50 条
  • [21] PREDICTING PROSTATE BIOPSY OUTCOME: PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3) ARE USEFUL BIOMARKERS
    Ferro, Matteo
    Montanaro, Vittorino
    Marsicano, Mariano
    Capece, Marco
    Terracciano, Daniela
    Sorrentino, Alessandra
    Marino, Ada
    Quarto, Giuseppe
    De Domenico, Renato
    Sorrentino, Domenico
    Altieri, Vincenzo
    Perdona, Sisto
    ANTICANCER RESEARCH, 2012, 32 (05) : 1940 - 1941
  • [22] Predicting prostate biopsy results—PCA3 versus phi
    Stacy Loeb
    Nature Reviews Urology, 2015, 12 : 130 - 131
  • [23] Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?
    Remzi, Mesut
    Haese, Alexander
    van Poppel, Hein
    de la Taille, Alexandre
    Stenzl, Arnulf
    Hennenlotter, Joerg
    Marberger, Michael
    BJU INTERNATIONAL, 2010, 106 (08) : 1138 - 1142
  • [24] INITIAL AND REPEAT PROSTATE BIOPSY: COMPARATIVE PERFORMANCE ANALYSIS OF PSA, %FPSA, PROSTATE VOLUME AND URINARY PCA3 INCLUDING DEVELOPMENT OF NOVEL PCA3 CUT-OFF THRESHOLDS
    Auprich, Marco
    van Poppel, Hendrik
    Marberger, Michael
    Stenzl, Arnulf
    Mulders, Peter F. A.
    Huland, Hartwig
    Abbou, Clement-Claude
    Stillebroer, Alexander B.
    van Gils, Martin P. M. Q.
    Schalken, Jack A.
    Fradet, Yves
    Marks, Leonard S.
    de la Taille, Alexandre
    Ellis, William
    Partin, Alan W.
    Haese, Alexander
    JOURNAL OF UROLOGY, 2011, 185 (04): : E930 - E930
  • [25] INITIAL PROSTATE BIOPSY: PCA3 OUTPERFORMS ESTABLISHED RISK FACTORS OF PROSTATE CANCER AND INCREASES MULTIVARIATE PREDICTIVE ACCURACY
    Auprich, M.
    Haese, A.
    Graefen, M.
    De La Taille, A.
    De Reijke, T.
    Kil, P.
    Stenzl, A.
    Van Poppel, H.
    Irani, J.
    Gontero, P.
    Marberger, M.
    Chun, F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 41 - 42
  • [26] INITIAL PROSTATE BIOPSY: PCA3 OUTPERFORMS ESTABLISHED RISK FACTORS OF PROSTATE CANCER AND INCREASES MULTIVARIATE PREDICTIVE ACCURACY
    Auprich, Marco
    Haese, Alexander
    de la Taille, Alexandre
    Graefen, Markus
    Kil, Paul
    Gontero, Paolo
    van Poppel, Hendrik
    Stenzl, Arnulf
    de Reijke, Theo
    Marberger, Michael
    Chun, Felix
    JOURNAL OF UROLOGY, 2010, 183 (04): : E838 - E838
  • [27] Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions
    de la Taille, Alexandre
    Irani, Jacques
    Graefen, Markus
    Chun, Felix
    de Reijke, Theo
    Kil, Paul
    Gontero, Paolo
    Mottaz, Alain
    Haese, Alexander
    JOURNAL OF UROLOGY, 2011, 185 (06): : 2119 - 2125
  • [28] Value of urinary PCA3 test for prostate cancer diagnosis
    Vlaeminck-Guillem, V.
    Ruffion, A.
    Andre, J.
    PROGRES EN UROLOGIE, 2008, 18 (05): : 259 - 265
  • [29] Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
    Wu, A. K.
    Reese, A. C.
    Cooperberg, M. R.
    Sadetsky, N.
    Shinohara, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (01) : 100 - 105
  • [30] Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
    A K Wu
    A C Reese
    M R Cooperberg
    N Sadetsky
    K Shinohara
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 100 - 105
12345